Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 23.69%, near the low end of its 5-year range (0.00%–50.25%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 14.86%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
14.86%
DEBT TO ASSETS RATIO AVG 3Y
29.77%
DEBT TO ASSETS RATIO AVG 5Y
23.69%
DEBT TO ASSETS RATIO AVG 10Y
14.34%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Kyntra Bio, Inc.
Market Cap
$24.01M
Debt to Assets Ratio
0.00%
TTM Avg
14.86%
3Y Avg
29.77%
5Y Avg
23.69%
Market Cap
$24.18M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.64M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.15M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.90M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.84M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.00M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.84M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyntra Bio, Inc. (KYNB) | $24.01M | 0.00% | 14.86% | 29.77% | 23.69% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.18M | 0.09% | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.64M | 0.00% | N/A | N/A | N/A |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.15M | 0.15% | N/A | N/A | N/A |
| Rein Therapeutics Inc. (RNTX)vs › | $22.90M | 0.00% | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.64M | 0.01% | N/A | N/A | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $25.84M | 0.01% | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 0.17% | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $21.84M | 0.02% | N/A | N/A | N/A |
| InspireMD, Inc. (NSPR)vs › | $26.89M | 0.04% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
N/A
Current Ratio
2.69
Interest Coverage
-5.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 17.56% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 15.36% |
| 2025-06-30 | 41.41% |
| 2025-03-31 | 44.44% |
| 2024-12-31 | 34.07% |
| 2024-09-30 | 30.00% |
| 2024-06-30 | 49.93% |
| 2024-03-31 | 50.25% |
| 2023-12-31 | 40.25% |
| 2023-09-30 | 33.36% |
| 2023-06-30 | 30.33% |
| 2023-03-31 | 16.12% |
| 2022-12-31 | 14.73% |
| 2022-09-30 | 15.21% |
| 2022-06-30 | 13.70% |
| 2022-03-31 | 12.99% |
| 2021-12-31 | 12.89% |
| 2021-09-30 | 12.03% |
| 2021-06-30 | 12.98% |
| 2021-03-31 | 4.83% |
| 2020-12-31 | 4.81% |
| 2020-09-30 | 5.19% |
| 2020-06-30 | 5.62% |
| 2020-03-31 | 5.82% |
| 2019-12-31 | 6.05% |
| 2019-09-30 | 6.05% |
| 2019-06-30 | 6.25% |
| 2019-03-31 | 7.39% |
| 2018-12-31 | 11.03% |
| 2018-09-30 | 11.37% |
| 2018-06-30 | 11.20% |
| 2018-03-31 | 11.25% |
| 2017-12-31 | 10.88% |
| 2017-09-30 | 10.88% |
| 2017-06-30 | 17.96% |
| 2017-03-31 | 22.08% |
| 2016-12-31 | 20.73% |
| 2016-09-30 | 20.03% |
| 2016-06-30 | 19.51% |
| 2016-03-31 | 21.94% |
| 2015-12-31 | 20.62% |
| 2015-09-30 | 19.43% |
| 2015-06-30 | 17.90% |
| 2015-03-31 | 22.24% |
| 2014-12-31 | 20.11% |
| 2014-09-30 | 28.16% |
| 2014-06-30 | 26.01% |
| 2014-03-31 | 40.62% |
| 2013-12-31 | 32.60% |
